Pathology Companies, December 2014 (p2)

24/7 Customer Support

Talk to Sam

+1 718 473 0872

All regions

About 200 Companies

Read our Company Profiles

Immunomedics Inc.

United States

Incyte Corp.

United States

Shire PLC

United Kingdom

OPKO Health Inc.

United States

Aphios Corp.

United States

Biocon Ltd.

India

Pharmacyclics Inc.

United States

Hospira Inc.

United States

Forest Laboratories Inc.

United States

Exelixis Inc.

United States

Bionomics Ltd.

Australia

C.R. Bard Inc.

United States

Genzyme Corp.

United States

Baxter Healthcare Corp.

United States

Evotec AG

Germany

LG Life Sciences Ltd.

South Korea

Seattle Genetics Inc.

United States

Pharma Mar S.A.

United States

Biogen Idec Inc.

United States

Celltech Group Ltd.

United Kingdom

Merck and Company Inc.

United States


About 4 400 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 55 - $ 10 995)

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cance ...

Ulcerative Colitis: Kol Insight

December 2014 $ 8 119

Russia Hiv/aids, Dalys

May 2013 $ 250

Cyprus Hiv/aids, Dalys

May 2013 $ 250

Gambia Gonorrhoea, Dalys

May 2013 $ 250

Moldova Chlamydia, Dalys

May 2013 $ 250

Angola Syphilis, Dalys

May 2013 $ 250

Bahamas Gonorrhoea, Dalys

May 2013 $ 250

Key Pharma News 15 September 2014

September 2014 $ 1 415

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.